Global footprint Piramal Group operates in over 30 countries with a presence in more than 100 global markets, indicating substantial cross-border sales potential and the need for regionally tailored outreach across pharma, financial services, and real estate.

Diverse business mix Active in Pharma, Financial Services, and Real Estate, the group offers multiple cross-selling opportunities such as pharma supply-chain capabilities paired with financial services for distributors or healthcare providers, and real estate developments that may require financing or advisory services.

Growth momentum Recent announcements show expansion in manufacturing capacity in the United States and new tower developments, signaling appetite for strategic partnerships, contract manufacturing opportunities, and project financing or advisory services.

Strategic partnerships Collaborations like the ICICI Bank lending partnership for rural and semi-urban credit access highlight openness to fintech, risk assessment, and customer financing collaborations that could be extended to other markets or financing products.

Sustainability and impact Piramal Foundation drives healthcare, education, and water initiatives impacting millions, presenting joint program funding, CSR-aligned partnerships, and ESG-aligned investment opportunities that can complement sales proposals for government and corporate clients.